财经调查丨防晒产品“伪装”成医疗器械，药店公然刷医保销售

Core Viewpoint - The article highlights the practice of marketing sunscreen products as "medical isolation pads" to exploit insurance reimbursement opportunities, revealing a trend in the pharmaceutical retail industry that blurs the lines between medical and non-medical products [1]. Group 1: Product Mislabeling - A sunscreen ice sleeve is marketed as a "medical isolation pad" to enable insurance reimbursement [1]. - The product's labeling as "medical" allows it to be sold in pharmacies and processed through health insurance, despite being a non-medical item [1]. Group 2: Market Strategy - The manufacturer, Henan Chaoya New Materials Co., has leveraged the "medical-grade" label to capture a larger market share and increase profits [1]. - The company has partnered with a leading pharmacy chain, resulting in an order worth 90 million yuan (approximately 13 million USD) for sunscreen masks and sleeves distributed to nearly 20,000 pharmacies nationwide [1]. Group 3: Regulatory Environment - "Medical isolation pads" are classified as Class I medical devices, which have lower risks and simpler registration processes, allowing non-medical products to meet compliance requirements [1]. - These products are assigned a unique 27-digit medical insurance code, enabling them to qualify for insurance reimbursement in certain regions [1].